Hot Life Science Investor Mandate 3: Corporate Venture Capital Fund of Large Pharma Company Seeking Innovative Therapeutic, Device, Diagnostic and HIT Opportunities

2 Jul

The corporate venture arm of a large biotech firm utilizes an evergreen structure and currently holds $750 million in assets under management. The fund invests separately from its parent and is not mandated to invest in areas of strategic relevance with it parent. The firm makes equity investments in early venture rounds. The firm typically invests up to $10 million initially with a total of $15-25 million going to a single company over multiple financing rounds. The firm is willing to both lead and co-invest in companies located around the globe and could make as many as 5-6 investments over the next year.

The firm invests in therapeutics, medical devices, diagnostics, and healthcare IT. The firm invests in early stages of development, from preclinical through to Phase IIa drug trials for therapeutics; and for medical devices and diagnostics, the firm prefers to invest in companies that are anywhere from in-development to on the market.  The firm is interested in all classes and indications of therapeutics, devices, and diagnostics with their main focus being that the technology be truly innovative and novel. They are not interested in cases of reformulations, repurposing or “me too” ideas. The firm makes approximately 75% of its investment in therapeutics and 25% across medical devices, diagnostics and healthcare IT although they are actively looking to increase exposure in these areas. The firm is also open to investing in laboratory equipment and drug development enabling technologies though this area is less of a focus.

The firm prefers to invest in management teams that have demonstrated prior success in the life science industry and are oriented on the goal of bringing a product to market. The firm is currently most interested in privately held companies and looks to take a board seat following investments.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: